Literature DB >> 3885984

The evaluation of domperidone and metoclopramide as antiemetics in day care abortion patients.

C S Waldmann, C Verghese, S M Short, D R Goldhill, S J Evans.   

Abstract

A randomised double-blind investigation was undertaken to assess the value of domperidone and metoclopramide as prophylactic anti-emetics in unpremedicated patients undergoing general anaesthesia for therapeutic abortion on a day care basis. Sixty patients were divided into three groups, and received, at induction, one of three drugs intravenously. The incidences of postoperative nausea and vomiting were 35% in the group receiving normal saline as placebo, 30% in the group receiving 10 mg domperidone and 25% in the group receiving 10 mg metoclopramide; these were not statistically significantly different. Furthermore, there was no statistically significant difference in the incidence of postoperative nausea and vomiting as influenced by age, weight, length of gestation, anaesthetic time and a history of nausea and vomiting during the pregnancy.

Entities:  

Keywords:  Abortion, Induced; Abortion, Therapeutic; Anesthesia--complications; Biology; Comparative Studies; Developed Countries; Diseases; Drugs; England; Europe; Family Planning; Fertility Control, Postconception; Gastrointestinal Effects; Nausea; Northern Europe; Physiology; Research Methodology; Signs And Symptoms; Studies; Treatment; United Kingdom; Vomiting

Mesh:

Substances:

Year:  1985        PMID: 3885984      PMCID: PMC1463742          DOI: 10.1111/j.1365-2125.1985.tb02648.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Postanesthetic nausea and vomiting.

Authors:  J W BELLVILLE
Journal:  Anesthesiology       Date:  1961 Sep-Oct       Impact factor: 7.892

2.  Pharmacology and toxicology of trichloroethylene. A critical review of the literature.

Authors:  R J DEFALQUE
Journal:  Clin Pharmacol Ther       Date:  1961 Sep-Oct       Impact factor: 6.875

3.  Anaesthesia for minor gynaecological operations.

Authors:  C S JONES
Journal:  S Afr Med J       Date:  1960-02-20

4.  Metoclopramide and perphenazine in the prevention of postoperative nausea and vomiting.

Authors:  B Lind; H Breivik
Journal:  Br J Anaesth       Date:  1970-07       Impact factor: 9.166

5.  The prevention of postoperative vomiting after abortion: metoclopramide.

Authors:  M M Clark; J A Storrs
Journal:  Br J Anaesth       Date:  1969-10       Impact factor: 9.166

6.  Comparison of domperidone, droperidol, and metoclopramide in the prevention and treatment of nausea and vomiting after balanced general anesthesia.

Authors:  K Korttila; A Kauste; J Auvinen
Journal:  Anesth Analg       Date:  1979 Sep-Oct       Impact factor: 5.108

7.  Double-blind evaluation of metoclopramide (MK 745, Sinemet), trimethobenzamide (Tigan), and a placebo as postanaesthetic anti-emetics following methoxyflurane anaesthesia.

Authors:  A B Dobkin; W Evers; J S Israel
Journal:  Can Anaesth Soc J       Date:  1968-01

8.  Nausea and vomiting during spinal anaesthesia. Effect of metoclopramide and domperidone: a double-blind trial.

Authors:  K R Spelina; H R Gerber; I L Pagels
Journal:  Anaesthesia       Date:  1984-02       Impact factor: 6.955

9.  Domperidone in the prevention of post-operative nausea and vomiting.

Authors:  M Boulanger; A Dubois; L Lecron
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

  9 in total
  2 in total

Review 1.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

2.  Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.

Authors:  Stephanie Weibel; Gerta Rücker; Leopold Hj Eberhart; Nathan L Pace; Hannah M Hartl; Olivia L Jordan; Debora Mayer; Manuel Riemer; Maximilian S Schaefer; Diana Raj; Insa Backhaus; Antonia Helf; Tobias Schlesinger; Peter Kienbaum; Peter Kranke
Journal:  Cochrane Database Syst Rev       Date:  2020-10-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.